Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc Aktie (CRNX) Neueste Nachrichten

Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High at $51.60 - MarketBeat

MarketBeat

Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock Rating Reaffirmed by Cantor Fitzgerald - Defense World

Defense World

Victory Capital Management Inc. Raises Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat

MarketBeat

Where are the Opportunities in (CRNX) - Stock Traders Daily

Stock Traders Daily

Victory Capital Management Inc. Buys 139117 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World

Defense World

Crinetics Pharmaceuticals (NASDAQ:CRNX) Given Overweight Rating at Cantor Fitzgerald - MarketBeat

MarketBeat

Crinetics Pharmaceuticals executive sells $148k in company stock - Investing.com India

Investing.com India

18 Analysts Have This To Say About Crinetics Pharmaceuticals - Crinetics Pharmaceuticals (NASDAQ:CRNX) - Benzinga

Benzinga

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Stephen F. Betz Sells 3,000 Shares - MarketBeat

MarketBeat

Crinetics Pharmaceuticals, Inc. (CRNX) Shares March Higher, Can It Continue? - Yahoo News UK

Yahoo News UK

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Crinetics Pharmaceuticals (NASDAQ:CRNX) Receives “Market Outperform” Rating from JMP Securities - Defense World

Defense World

Crinetics Pharmaceuticals (NASDAQ:CRNX) Earns Buy Rating from HC Wainwright - Defense World

Defense World

Richard Scott Struthers Sells 107448 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Stock - Defense World

Defense World

Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen solid returns of 196% over the past three years - Yahoo Finance

Yahoo Finance

Crinetics Pharmaceuticals (NASDAQ:CRNX) Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPS - MarketBeat

MarketBeat

Crinetics Pharmaceuticals CEO sells $5.3 million in stock - Investing.com India

Investing.com India

Crinetics Pharmaceuticals' (CRNX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

MarketBeat

Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire

Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Crinetics Pharmaceuticals CEO sells $5.3 million in stock By Investing.com - Investing.com Australia

Investing.com Australia

Crinetics Pharmaceuticals CEO sells $5.3 million in stock By Investing.com - Investing.com

Investing.com

Crinetics Pharmaceuticals Inc (CRNX) Reports Q1 2024 Financial Results - Yahoo Finance

Yahoo Finance

Crinetics Pharmaceuticals CEO sells $5.3 million in stock - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Yahoo Finance

Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update - 09.05.2024 - wallstreet:online

wallstreet:online

Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update - Investing.com South Africa

Investing.com South Africa

Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High on Analyst Upgrade - Defense World

Defense World

Crinetics Pharmaceuticals Showcases Research at ENDO 2024 - TipRanks.com - TipRanks

TipRanks

Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development ... - Yahoo Finance

Yahoo Finance

Crinetics Pharmaceuticals (NASDAQ:CRNX) Sets New 12-Month High on Analyst Upgrade - MarketBeat

MarketBeat

Crinetics Pharmaceuticals (CRNX) to Release Quarterly Earnings on Thursday - Defense World

Defense World

Crinetics Pharmaceuticals (NASDAQ:CRNX) Given New $97.00 Price Target at Piper Sandler - Defense World

Defense World

Is Crinetics Pharmaceuticals (CRNX) Stock a Solid Choice Right Now? - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

(CRNX) Technical Data - Stock Traders Daily

Stock Traders Daily

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo New Zealand News

Yahoo New Zealand News

Crinetics Pharmaceuticals (CRNX) Scheduled to Post Earnings on Thursday - MarketBeat

MarketBeat

Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewswire

GlobeNewswire

Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024

GlobeNewswire Inc.

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Up 6.3% in April - MarketBeat

MarketBeat

abrdn plc Purchases New Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - MarketBeat

MarketBeat

Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen stellar returns of 142% over the past three years - Simply Wall St

Simply Wall St

Crinetics Pharmaceuticals executive sells shares worth over $639k - Investing.com

Investing.com

Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Technical Analysis of Crinetics Pharmaceuticals — TradingView News - TradingView

TradingView

Crinetics Pharmaceuticals CEO sells over $2m in company stock - Investing.com Nigeria

Investing.com Nigeria

Crinetics Pharmaceuticals Launches New Deferred Compensation Plan - TipRanks.com - TipRanks

TipRanks

Crinetics, Syndax stocks gain amid pitch at Sohn charity conference (NASDAQ:CRNX) - Seeking Alpha

Seeking Alpha

Crinetics Pharmaceuticals director sells $811,650 in stock By Investing.com - Investing.com

Investing.com

Insider Sell: COO Jeff Knight Sells 32,359 Shares of Crinetics Pharmaceuticals Inc (CRNX) - Yahoo Finance

Yahoo Finance